Girl Dies as Pluristem Therapeutics Sells on Gains With Miracle Cells

This article was originally published here

Pluristem Therapeutics Inc.s stock doubled in Nasdaq trading from May through September, helped by three news releases announcing that patients lives had been saved by injections of the companys experimental stem cells. the stock soared on the positive news, two top executives profited by selling shares at the highest price in more than four years as part of a pre-determined program. When the first…

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply